Advisor Group Holdings »

Diamedica Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8k 1.0k 2.84
2023-09-30 $2.6k 1.0k 2.58
2023-06-30 $4 1 4.00

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Diamedica Therapeutics

Vanguard Group
Paragon Associates & Paragon Associates Ii Joint Venture
Bleichroeder
Catalyst Financial Partners
Millennium Management
Citadel Advisors
Bank of New York Mellon
Jane Street
Stonebridge Capital Advisors
Dimensional Fund Advisors
Bnp Paribas Arbitrage, Snc
Charles Schwab Investment Management
H D Vest Advisory Services
Massmutual Trust
Us Bancorp

View all funds holding Diamedica Therapeutics